AMENDMENT TO SUBSCRIPTION AGREEMENTSubscription Agreement • May 16th, 2018 • Concordia International Corp. • Pharmaceutical preparations • Ontario
This Amendment (this “Amendment”) dated as of May 12, 2018, among (a) Concordia International Corp. (“Concordia”), (b) Concordia Healthcare (Canada) Limited (“CHCL”), (c) each of the affiliates and subsidiaries of Concordia listed on Schedule D to the Subscription Agreement (as defined below) (collectively, the “Subsidiary Guarantors”, and together with Concordia and CHCL, the “Company”), and (d) each of the other signatories hereto (each a Private Placement Party, as defined below) amends the Subscription Agreement dated as of May 1, 2018 (the “Subscription Agreement”) among Concordia, CHCL, the Subsidiary Guarantors, and the other signatories to the Subscription Agreement listed in Schedule E thereto (together with such signatories’ Permitted Transferees (as defined in the Subscription Agreement), each a “Private Placement Party” and collectively the “Private Placement Parties”). The Company and the Private Placement Parties that are signatories to this Amendment are collectively ref
